btgd_anaiysis

The chart shows the growth of an initial investment of $10,000 in btgd_anaiysis, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Oct 16, 2024, btgd_anaiysis's average daily return is +0.08%, while the average monthly return is +1.42%. At this rate, an investment would double in approximately 4.1 years.

Historically, 52% of months were positive and 48% were negative. The best month was Nov 2024 with a return of +17.8%, while the worst month was Feb 2025 at -7.8%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 3 months.

On a daily basis, btgd_anaiysis closed higher 52% of trading days. The best single day was Nov 11, 2024 with a return of +6.1%, while the worst single day was Feb 5, 2026 at -7.2%.

btgd_anaiysis has an annualized alpha of 7.29%, beta of 0.71, and R2 of 0.19 versus S&P 500 Index. Calculated based on daily prices since October 16, 2024.

• This portfolio participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (86.93%) than losses (79.84%) - typical of diversified or defensive assets.
• R2 of 0.19 means this portfolio moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

btgd_anaiysis has an expense ratio of 0.68%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

btgd_anaiysis ranks 2 for risk / return — in the bottom 2% of Portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk. Learn how to interpret the Sharpe ratio.

The current btgd_anaiysis Sharpe ratio is -0.35 as of Jun 13, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.56 to 2.44, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of btgd_anaiysis compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

btgd_anaiysis provided a 33.20% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the btgd_anaiysis. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the btgd_anaiysis was 27.51%, occurring on Jun 10, 2026. The portfolio has not yet recovered.

The current btgd_anaiysis drawdown is 25.41%.

The chart below shows the rolling one-month volatility.